| http://www.w3.org/ns/prov#value | - With more than 200,000 patients per year presenting with Cancer of Unknown or Uncertain Primary (CUP) or who would otherwise benefit from this test, this expanding coverage reflects the importance of determining the tumor origin in hard-to-diagnose metastatic cancers and CUP. This is particularly important as new, molecularly-targeted cancer treatments are developed.
|
